Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Waters
(NYSE:WAT)
Intraday
$311.30
2.95
[0.96%]
After-Hours
$311.30
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$311.30
2.95
[0.96%]
At close: Apr 26
$311.30
0
[0.00%]
After Hours: 4:00PM EDT
Get Report
Watch
Q1 2024 Earnings in 10 days from now on Tue May 7th, before the market open
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Waters Stock (NYSE:WAT)
Waters Stock (NYSE: WAT)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, April 23, 2024
Shares of life sciences tools stocks are trading higher following strong earnings from Danaher.
Benzinga Newsdesk
-
3 days ago
Monday, April 22, 2024
Waters Accelerates The Development Of Gene-based Therapeutics With New GTxResolve Premier SEC Columns
Benzinga Newsdesk
-
4 days ago
Tuesday, April 09, 2024
Waters Corporation Unveils Alliance iS Bio HPLC System To Help Biopharma QC Labs Increase Efficiency And Reduce Errors
Benzinga Newsdesk
-
Apr 9, 2024, 3:43AM
Thursday, April 04, 2024
Navigating 4 Analyst Ratings For Waters
Benzinga Insights
-
Apr 4, 2024, 5:00PM
Evercore ISI Group Maintains In-Line on Waters, Raises Price Target to $340
Benzinga Newsdesk
-
Apr 4, 2024, 1:05PM
Wednesday, March 13, 2024
Top 7 Biotech Stock Winners As Weight Loss Drug Battle Escalates: Goldman Sachs Names Best Picks
Piero Cingari
-
Mar 13, 2024, 12:35PM
Monday, February 12, 2024
A Glimpse Into The Expert Outlook On Waters Through 4 Analysts
Benzinga Insights
-
Feb 12, 2024, 1:00PM
Tuesday, February 06, 2024
Waters Q4 Earnings Beats Estimates, CEO Touts Strong Execution In Tough Market Conditions
Nabaparna Bhattacharya
-
Feb 6, 2024, 1:34PM
Waters Corp Expects Q1 Organic Constant Currency Sales Growth Of -11% To -9%, Reported Sales Growth Of -8.5% To -6.5%; Adj EPS Of $2.05-$2.15 (Est $2.39)
Benzinga Newsdesk
-
Feb 6, 2024, 6:55AM
Waters Corp. Expects Full-Year 2024 Organic Constant Currency Sales Growth To Be -0.5% To +1.5%; Reported Sales Growth Of 0% To +2%; Ad EPS Of $11.75-$12.05 (Est. $11.98)
Benzinga Newsdesk
-
Feb 6, 2024, 6:53AM
Waters Q4 Adj EPS $3.62 Beats $3.55 Estimate, Sales $819.47M Beat $815.03M Estimate
Benzinga Newsdesk
-
Feb 6, 2024, 6:51AM
Earnings Scheduled For February 6, 2024
Benzinga Insights
-
Feb 6, 2024, 5:42AM
Thursday, January 25, 2024
The Latest Analyst Ratings For Waters
Benzinga Insights
-
Jan 25, 2024, 1:00PM
Barclays Maintains Underweight on Waters, Raises Price Target to $275
Benzinga Newsdesk
-
Jan 25, 2024, 9:59AM
Wednesday, December 13, 2023
Wolfe Research Initiates Coverage On Waters with Peer Perform Rating
Benzinga Newsdesk
-
Dec 13, 2023, 4:56AM
Monday, December 11, 2023
Where Waters Stands With Analysts
Benzinga Insights
-
Dec 11, 2023, 8:00AM
Citigroup Maintains Neutral on Waters, Raises Price Target to $300
Benzinga Newsdesk
-
Dec 11, 2023, 7:15AM
Wednesday, December 06, 2023
Waters Inaugurated Its New Global Capability Center In A Newly Built Facility In Bengaluru's RMZ Ecoworld Technology Park, The New $16M Workspace Will Employ 300+ For Roles That Were Formerly Outsourced
Benzinga Newsdesk
-
Dec 6, 2023, 6:36AM
Tuesday, November 21, 2023
Agilent Posts Upbeat Results, Joins Burlington Stores, Hibbett And Other Big Stocks Moving Higher On Tuesday
Lisa Levin
-
Nov 21, 2023, 11:42AM
Friday, November 17, 2023
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
-
Nov 17, 2023, 12:35PM
Monday, November 13, 2023
What 6 Analyst Ratings Have To Say About Waters
Benzinga Insights
-
Nov 13, 2023, 10:00AM
HP To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Monday
Lisa Levin
-
Nov 13, 2023, 8:32AM
Barclays Downgrades Waters to Underweight, Lowers Price Target to $230
Benzinga Newsdesk
-
Nov 13, 2023, 8:20AM
Wednesday, November 08, 2023
Stifel Maintains Hold on Waters, Lowers Price Target to $290
Benzinga Newsdesk
-
Nov 8, 2023, 4:15PM
JP Morgan Maintains Neutral on Waters, Lowers Price Target to $250
Benzinga Newsdesk
-
Nov 8, 2023, 3:50PM
Wells Fargo Maintains Equal-Weight on Waters, Lowers Price Target to $285
Benzinga Newsdesk
-
Nov 8, 2023, 9:24AM
Tuesday, November 07, 2023
What's Going On With Laboratory Instrument & Software Company Waters' Shares Today?
Nabaparna Bhattacharya
-
Nov 7, 2023, 12:56PM
Waters Sees FY23 Adjusted EPS Of $11.65-$11.75 Versus Prior Guidance Of $12.20-$12.30 And Consensus Of $12.13
Benzinga Newsdesk
-
Nov 7, 2023, 6:58AM
Waters Expects FY23 Reported Sales Growth Of -1%-Flat Versus Prior Range Of 3%-4%
Benzinga Newsdesk
-
Nov 7, 2023, 6:56AM
Waters Q3 Adjusted EPS $2.84 Beats $2.55 Estimate, Sales $711.69M Miss $723.35M Estimate
Benzinga Newsdesk
-
Nov 7, 2023, 6:52AM
Earnings Scheduled For November 7, 2023
Benzinga Insights
-
Nov 7, 2023, 6:34AM
Tuesday, October 17, 2023
JP Morgan Maintains Neutral on Waters, Lowers Price Target to $260
Benzinga Newsdesk
-
Oct 17, 2023, 1:40PM
Thursday, September 28, 2023
Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2023
Benzinga Insights
-
Sep 28, 2023, 11:00AM
The Latest Analyst Ratings for Waters
Benzinga Insights
-
Sep 28, 2023, 11:00AM
Bernstein Initiates Coverage On Waters with Market Perform Rating, Announces Price Target of $280
Benzinga Newsdesk
-
Sep 28, 2023, 6:27AM
Wednesday, September 13, 2023
US Stocks Rise Despite Hot Inflation As Fed Sentiment Remains Unshaken: What's Driving Markets Wednesday?
Shanthi Rexaline
-
Sep 13, 2023, 1:13PM
Thursday, August 03, 2023
Barclays Maintains Equal-Weight on Waters, Raises Price Target to $288
Benzinga Newsdesk
-
Aug 3, 2023, 8:40AM
Wednesday, August 02, 2023
Waters Corporation shares are trading higher after the company reported better-than-expected Q2 results.
Benzinga Newsdesk
-
Aug 2, 2023, 1:51PM
Why Exact Sciences Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin
-
Aug 2, 2023, 1:07PM
Humana, Waters, e.l.f. Beauty, Teva Pharmaceutical And Other Big Stocks Moving Higher On Wednesday
Lisa Levin
-
Aug 2, 2023, 10:36AM
Earnings Scheduled For August 2, 2023
Benzinga Insights
-
Aug 2, 2023, 8:45AM
Waters Corp Expects Q3 Sales Growth Of 1%-3% Vs $769.19M Est, Adj EPS $2.50-$2.60 Vs $3.01 Est; FY23 Sales Growth 3%-4% (Prior 5.5%-7.5%) Vs $3.13B Est, Adj EPS 12.20-$12.30 (Prior $12.55-$12.75) Vs $12.45 Est
Benzinga Newsdesk
-
Aug 2, 2023, 6:59AM
Waters Q2 Adj EPS $2.80 Beats $2.59 Estimate, Sales $740.58M Beat $733.51M Estimate
Benzinga Newsdesk
-
Aug 2, 2023, 6:51AM
Monday, July 31, 2023
10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights
-
Jul 31, 2023, 1:35PM
Waters Corporation shares are trading lower after Barclays downgraded the stock from Overweight to Equal-Weight. Additionally, Evercore ISI Group downgraded the stock from Outperform to In-Line and lowered its price target from $285 to $270.
Benzinga Newsdesk
-
Jul 31, 2023, 1:08PM
Benzinga's Top Ratings Upgrades, Downgrades For July 31, 2023
Benzinga Insights
-
Jul 31, 2023, 11:00AM
Rising Stars, Falling Trends: July's Industry ETF Winners And Losers
Piero Cingari
-
Jul 31, 2023, 10:59AM
Barclays Downgrades Waters to Equal-Weight, Announces $275 Price Target
Benzinga Newsdesk
-
Jul 31, 2023, 9:25AM
Expert Ratings for Waters
Benzinga Insights
-
Jul 31, 2023, 8:00AM
Evercore ISI Group Downgrades Waters to In-Line, Lowers Price Target to $270
Benzinga Newsdesk
-
Jul 31, 2023, 7:11AM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch